Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

A protein called sFRP4 can slow down hair regrowth.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

A new automated method accurately measures hair damage using microscopic images.

Reliable method detects finasteride in human plasma at low doses.

Rat hair follicle stem cells can be successfully cultured and may be useful for creating tissue-engineered hair, vessels, and skin.

Researchers developed a new skin patch that delivers more finasteride into the skin, potentially improving treatment for hair loss and prostate issues.

Scientists created a detailed map of gene activity in different parts of human hair follicles.

Accurate method measures finasteride levels in human plasma using gas chromatography-mass spectrometry.

Peficitinib can turn human fibroblasts into cells that help grow hair.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition with inflammation and scarring, resembling but distinct from common balding.

The study found that treatment improved hair condition in patients with Fibrosing Alopecia in a Pattern Distribution in Chile.

Folate receptor β helps suppress the immune system in macrophages and affects cancer growth and hair health.

New, cheaper method measures finasteride in tablets accurately and quickly.

The best method to monitor dutasteride in rat plasma is liquid-liquid extraction with methyl tert-butyl ether and methylene chloride.

Plucked human hair can be used to study drug effects on certain cell markers.

The new method provides more accurate vibrational frequencies for drug molecules than traditional models.

The study found that a specific type of hair loss is increasingly common in premenopausal women and can be effectively diagnosed and treated with various medications.

TrichoScan offers a painless way to analyze and manage hair loss.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Hair follicle testing is more reliable and effective for drug screening than urinalysis.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

The method accurately measures Finasteride and Tamsulosin in tablets without interference.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

A new method accurately measures three compounds in rat plasma from pine needle extracts, aiding future research on its use for hair loss.